Stimulation of NPY Y2 receptors by PYY3-36 reveals divergent cardiovascular effects of endogenous NPY in rats on different dietary regimens

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 286, Issue 1 55-1, 2004, Pages

  Nordheim, Ulrich ^a   Hofbauer, Karl G ^a,b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Blood pressure; Heart rate; Neuropeptide Y; Peptide YY; Sympathetic nerve activity

Indexed keywords

GASTROINTESTINAL HORMONE; NEUROPEPTIDE Y; NEUROPEPTIDE Y2 RECEPTOR; PEPTIDE YY; SODIUM CHLORIDE; NEUROPEPTIDE Y RECEPTOR; PEPTIDE YY (3 36); PEPTIDE YY (3-36);

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DIET; DIET RESTRICTION; HEART RATE; LIPID DIET; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SYMPATHETIC NERVE; TELEMETRY; ANIMAL; CARDIOVASCULAR FUNCTION; DRUG EFFECT; EATING; FAT INTAKE; FOOD DEPRIVATION; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CARDIOVASCULAR PHYSIOLOGY; DIET; DIETARY FATS; EATING; FOOD DEPRIVATION; MALE; NEUROPEPTIDE Y; PEPTIDE YY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE Y;

EID: 0347357950     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00374.2003     Document Type: Article

References (30)

1. Adrian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, and Bloom SR. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 89: 1070-1077, 1985.
2. Aguirre JA, Fuxe K, Agnati LF, and von Euler G. Centrally injected neuropeptide Y (13-36) produces vasopressor effects and antagonizes the vasodepressor action of neuropeptide Y (1-36) in the awake male rat. Neurosci Lett 118: 5-8, 1990.
3. Astrup A. The role of dietary fat in the prevention and treatment of obesity. Efficacy and safety of low-fat diets. Int J Obes Relat Metab Disord 25: 46-50, 2001.
4. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, and Bloom SR. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418: 650-654, 2002.
5. Beck B, Jhanwar-Uniyal M, Burlet A, Chapleur-Chateau M, Leibowitz SF, and Burlet C. Rapid and localized alterations of neuropeptide Y in discrete hypothalamic nuclei with feeding status. Brain Res 528: 245-249, 1990.
6. Billington CJ, Briggs JE, Harker S, Grace M, and Levine AS. Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism. Am J Physiol Regul Integr Comp Physiol 266: R1765-R1770, 1994.
7. Broberger C, Landry M, Wong H, Walsh JN, and Hokfelt T. Subtypes of Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin-and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus. Neuroendocrinology 66: 393-408, 1997.
8. Carter DA, Vallejo M, and Lightman SL. Cardiovascular effects of neuropeptide Y in the nucleus tractus solitarius of rats: relationship with noradrenaline and vasopresssin. Peptides 6: 421-425, 1985.
9. Egawa M, Yoshimatsu H, and Bray GA. Neuropeptide Y suppresses sympathetic activity to intracapsular brown adipose tissue in rats. Am J Physiol Regul Integr Comp Physiol 260: R328-R334, 1991.
10. Harland D, Bennett T, and Gardiner SM. Cardiovascular actions of neuropeptide Y in the hypothalamic paraventricular nucleus of conscious Long Evans and Brattleboro rats. Neurosci Lett 85: 239-243, 1998.
11. Hashim MA and Tadepalli AS. Cutaneous vasomotor effects of neuropeptide Y. Neuropeptides 29: 263-271, 1995.
12. Iyengar S, Li DL, and Simmons RM. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding? J Pharmacol Exp Ther 289: 1031-1040, 1999.
13. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, and Kalra PS. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 20: 68-100, 1999.
14. Kanatani A, Mashiko S, Murai N, Sugimoto N, Ito J, Fukuroda T, Fukami T, Morin N, MacNeil DJ, Van der Ploeg LH, Saga Y, Nishimura S, and Ihara M. Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice. Endocrinology 141: 1011-1016, 2000.
15. Keire DA, Bowers CW, Solomon TE, and Reeve JR Jr. Structure and receptor binding of PYY analogs. Peptides 23: 305-321, 2002.
16. Lundberg JM and Modin A. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y Y1 receptor antagonist BIBP 3226. Br J Pharmacol 116: 2971-2982, 1995.
17. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, and Stamler J. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335: 765-774, 1990.
18. Malmström RE. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control. Acta Physiol Scand 160, Suppl 636: 1-55, 1997.
19. Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, Quirion R, Schwartz T, and Westfall T. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 50: 143-150, 1998.
20. Morton KDR, McCloskey MJD, and Potter EK. Cardiorespiratory responses to intracerebroventricular injection of neuropeptide Y in anaesthetised dogs. Regul Pept 81: 81-88, 1999.
21. Naveilhan P, Hassani H, Canals JM, Ekstrand AJ, Larefalk A, Chhajlani V, Arenas E, Gedda K, Svensson L, Thoren P, and Ernfors P. Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor. Nat Med 5: 1188-1193, 1999.
22. Pedersen-Bjergaard U, Host U, Kelbaek H, Schifter S, Rehfeld JF, Faber J, and Christensen NJ. Influence of meal composition on postprandial peripheral plasma concentrations of vasoactive peptides in man. Scand J Clin Lab Invest 56: 497-503, 1996.
23. Pernow J, Saria A, and Lundberg JM. Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control. Acta Physiol Scand 126: 239-249, 1986.
24. Rupp H and Maisch B. Radiotelemetric characterization of overweight-associated rises in blood pressure and heart rate. Am J Physiol Heart Circ Physiol 277: H1540-H1545, 1999.
25. Stricker-Krongrad A, Kozak R, Burlet C, Nicolas JP, and Beck B. Physiological regulation of hypothalamic neuropeptide Y release in lean and obese rats. Am J Physiol Regul Integr Comp Physiol 273: R2112-R2116, 1997.
26. Van Dijk G, Bottone AE, Strubbe JH, and Steffens AB. Hormonal and metabolic effects of paraventricular hypothalamic administration of neuropeptide Y during rest and feeding. Brain Res 660: 96-103, 1994.
27. VanNess JM, DeMaria JE, and Overton JM. Increased NPY activity in the PVN contributes to food-restriction induced reductions in blood pressure in aortic coarctation hypertensive rats. Brain Res 821: 263-269, 1999.
28. Wilding JP, Gilbey SG, Mannan M, Aslam N, Ghatei MA, and Bloom SR. Increased neuropeptide Y content in individual hypothalamic nuclei, but not neuropeptide Y mRNA, in diet-induced obesity in rats. J Endocrinol 132: 299-304, 1992.
29. Wilmore JH, Stanforth PR, Gagnon J, Rice T, Mandel S, Leon AS, Rao DC, Skinner JS, and Bouchard C. Heart rate and blood pressure changes with endurance training: the HERITAGE Family Study. Med Sci Sports Exerc 33: 107-116, 2001.
30. Young JB and Landsberg L. Suppression of sympathetic nervous system during fasting. Obes Res 5: 646-649, 1997.